Ionis Pharmaceuticals Inc (IONS)
41.97
-1.12
(-2.60%)
USD |
NASDAQ |
May 03, 16:00
41.97
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Accounts Payable (Quarterly): 26.03M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.03M |
September 30, 2023 | 5.615M |
June 30, 2023 | 24.02M |
March 31, 2023 | 10.50M |
December 31, 2022 | 17.92M |
September 30, 2022 | 20.54M |
June 30, 2022 | 10.35M |
March 31, 2022 | 16.12M |
December 31, 2021 | 11.90M |
September 30, 2021 | 8.357M |
June 30, 2021 | 14.66M |
March 31, 2021 | 9.506M |
December 31, 2020 | 17.20M |
September 30, 2020 | 16.22M |
June 30, 2020 | 7.407M |
March 31, 2020 | 21.17M |
December 31, 2019 | 16.07M |
September 30, 2019 | 13.15M |
June 30, 2019 | 15.63M |
March 31, 2019 | 13.33M |
December 31, 2018 | 28.66M |
September 30, 2018 | 13.58M |
June 30, 2018 | 13.29M |
March 31, 2018 | 13.83M |
December 31, 2017 | 24.89M |
Date | Value |
---|---|
September 30, 2017 | 23.52M |
June 30, 2017 | 13.27M |
March 31, 2017 | 23.24M |
December 31, 2016 | 21.12M |
September 30, 2016 | 15.68M |
June 30, 2016 | 17.58M |
March 31, 2016 | 19.46M |
December 31, 2015 | 28.36M |
September 30, 2015 | 19.29M |
June 30, 2015 | 10.95M |
March 31, 2015 | 16.49M |
December 31, 2014 | 17.98M |
September 30, 2014 | 15.63M |
June 30, 2014 | 13.45M |
March 31, 2014 | 9.869M |
December 31, 2013 | 11.01M |
September 30, 2013 | 8.781M |
June 30, 2013 | 9.461M |
March 31, 2013 | 5.385M |
December 31, 2012 | 10.24M |
September 30, 2012 | 5.256M |
June 30, 2012 | 6.194M |
March 31, 2012 | 5.344M |
December 31, 2011 | 8.30M |
September 30, 2011 | 6.653M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.615M
Minimum
Sep 2023
26.03M
Maximum
Dec 2023
14.86M
Average
15.63M
Median
Jun 2019
Accounts Payable (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 28.04M |
Viking Therapeutics Inc | 5.225M |
Alnylam Pharmaceuticals Inc | 78.15M |
Akero Therapeutics Inc | 7.038M |
89bio Inc | 8.585M |